BioSpace News Archive

Innovative Health Diagnostics (IHD), announced today a new partnership with AIMA Laboratories (AIMA), a preclinical FemTech company dedicated to developing new products that fill current gaps in gynecological health, to develop and deliver a new and reliable at-home blood test to detect endometriosis.

Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, today announced the publication of a peer-reviewed article in Clinical & Translational Immunology characterizing B cell repertoires in tissue samples from patients with breast cancer.

Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax ® personalized immune therapies for solid tumor cancers, today announced that it has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for the Company’s Pediatric Investigation Plan (PIP).

GeoBlue, the leader in high-tech, high-touch health insurance solutions for the globally mobile, announces the appointment of Simon Jackson as Chief Growth Officer, leading the organization’s Sales, Client Management, and Sales Effectiveness teams.

BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced its results for the three and six-month periods ended June 30, 2022.

ATCC today announced that it has been selected as an awardee for the National Cancer Institute’s (NCI) Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services contract.

Kyverna Therapeutics today announced the appointment of Georg Schett, M.D. and Peter A. Merkel, M.D. as Scientific Advisors.

New scientific findings offer hope and a natural solution to those who suffer from sensations of crawling, pulling, throbbing, aching and itching in the legs, often resulting in sleep disruption and the uncontrollable urge to move.

Acer Therapeutics Inc. (Nasdaq: ACER), today announced that Acer’s management team will virtually present at, and participate in, the upcoming Gilmartin Group Emerging Growth Company Showcase and H.C. Wainwright 24th Annual Global Investment Conference.

Hemanext Inc. today announced that it has entered into distribution agreements with two leading medical device distributors in the Nordics and Italy, bolstering its sales capabilities across key European markets and strengthening its relationships with key blood centers and clinicians in each region.